Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

por AlQahtani, Manaf, Kumar, Nitya, Aljawder, Dhuha, Abdulrahman, Abdulkarim, Mohamed, Mohammed Wael, Alnashaba, Fatema, Fayyad, Mohammed Abu, Alshaikh, Faisal, Alsahaf, Fatima, Saeed, Sawsan, Almahroos, Amal, Abdulrahim, Zainab, Otoom, Sameer, Atkin, Stephen L.
Publicado 2022

Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

por AlQahtani, Manaf, Kumar, Nitya, Aljawder, Dhuha, Abdulrahman, Abdulkarim, Mohamed, Mohammed Wael, Alnashaba, Fatema, Fayyad, Mohammed Abu, Alshaikh, Faisal, Alsahaf, Fatima, Saeed, Sawsan, Almahroos, Amal, Abdulrahim, Zainab, Otoom, Sameer, Atkin, Stephen L.
Publicado 2022